U.S. flag

An official website of the United States government

NM_001321075.3(DLG4):c.1479-2A>G AND Intellectual developmental disorder 62

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Oct 2, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001775266.8

Allele description [Variation Report for NM_001321075.3(DLG4):c.1479-2A>G]

NM_001321075.3(DLG4):c.1479-2A>G

Gene:
DLG4:discs large MAGUK scaffold protein 4 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_001321075.3(DLG4):c.1479-2A>G
HGVS:
  • NC_000017.11:g.7194002T>C
  • NG_008391.2:g.31049A>G
  • NG_008391.3:g.31048A>G
  • NM_001128827.4:c.1470-2A>G
  • NM_001321074.1:c.1599-2A>G
  • NM_001321075.3:c.1479-2A>GMANE SELECT
  • NM_001321076.3:c.1299-2A>G
  • NM_001321077.3:c.1299-2A>G
  • NM_001365.5:c.1608-2A>G
  • NM_001369566.3:c.1398-2A>G
  • NC_000017.10:g.7097321T>C
  • NM_001365.4:c.1608-2A>G
Links:
dbSNP: rs2142828286
NCBI 1000 Genomes Browser:
rs2142828286
Molecular consequence:
  • NM_001128827.4:c.1470-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001321074.1:c.1599-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001321075.3:c.1479-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001321076.3:c.1299-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001321077.3:c.1299-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001365.5:c.1608-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
  • NM_001369566.3:c.1398-2A>G - splice acceptor variant - [Sequence Ontology: SO:0001574]
Observations:
1

Condition(s)

Name:
Intellectual developmental disorder 62
Synonyms:
MENTAL RETARDATION, AUTOSOMAL DOMINANT 62; INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL DOMINANT 62
Identifiers:
MONDO: MONDO:0032919; MedGen: C5394083; OMIM: 618793

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV0020119963billion
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Oct 2, 2021)
unknownclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyes1not providednot provided1not providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From 3billion, SCV002011996.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function through nonsense-mediated decay (NMD) or protein truncation. Multiple pathogenic variants are reported downstream of the variant (PVS1_VS). It is not observed in the gnomAD v2.1.1 dataset (PM2). Therefore, this variant is classified as likely pathogenic according to the recommendation of ACMG/AMP guideline.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyes1not providednot provided1not providednot providednot provided

Last Updated: Dec 24, 2023